scholarly article | Q13442814 |
P2093 | author name string | Otvos L Jr | |
Celis E | |||
Ou D | |||
P4510 | describes a project that uses | synthetic peptide | Q104631433 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatitis B | Q6853 |
cytotoxicity | Q246181 | ||
P304 | page(s) | 1808-1815 | |
P577 | publication date | 1988-03-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides | |
P478 | volume | 140 |
Q24810147 | Advances in immunomodulating therapy of HBV infection |
Q36692862 | Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides |
Q27486237 | Analysis of murine major histocompatibility complex class II-restricted T-cell responses to the flavivirus Kunjin by using vaccinia virus expression |
Q42674331 | Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition. |
Q35823339 | Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease |
Q26826924 | Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics |
Q40836583 | Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines |
Q45881590 | Characterization of the specificity and genetic restriction of human CD4+ cytotoxic T cell clones reactive to capsid antigen of rubella virus |
Q36099102 | Chemoimmunotherapy of chronic hepatitis B virus infection in the woodchuck model overcomes immunologic tolerance and restores T-cell responses to pre-S and S regions of the viral envelope protein |
Q41704828 | Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector |
Q41703222 | Gamma-interferon induces differential expression of HLA-DR, -DP and -DQ in human ciliary epithelial cells |
Q64986774 | Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies. |
Q36690778 | Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens |
Q40951387 | Hepatitis B virus immunopathology |
Q39787946 | Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis |
Q36685422 | Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones |
Q36820442 | Identification of an immunodominant epitope within the phosphoprotein of rabies virus that is recognized by both class I- and class II-restricted T cells |
Q43932542 | Immune response to hepatitis B virus surface antigen peptides during HBV infection |
Q33637125 | Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis |
Q24529209 | In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model |
Q41138242 | Involvement of CD80 in the generation of CD4+ cytotoxic T cells. |
Q36362505 | Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis |
Q35887445 | Novel and frequent mutations of hepatitis B virus coincide with a major histocompatibility complex class I-restricted T-cell epitope of the surface antigen |
Q36780717 | Presentation of an immunodominant T-cell epitope of hepatitis B surface antigen by the HLA-DPw4 molecule. |
Q37556764 | T cell epitope: friend or foe? Immunogenicity of biologics in context |
Q40109002 | T- and B-lymphocyte responses to human immunodeficiency virus (HIV) type 1 in macaques immunized with hybrid HIV/hepatitis B surface antigen particles |
Q35816248 | The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. |
Q44368778 | The spot-ELISA: a sensitive in vitro method to study the immune response to hepatitis B surface antigen. |
Q41887540 | Transferrin receptor mediates uptake and presentation of hepatitis B envelope antigen by T lymphocytes |
Search more.